Literature DB >> 7884509

Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.

T Ohtake1, I Yokoyama, T Watanabe, T Momose, T Serezawa, J Nishikawa, Y Sasaki.   

Abstract

UNLABELLED: Diabetes mellitus (DM) is one of several factors influencing the assessment of myocardial viability using fluorine-18 fluorodeoxyglucose (FDG) PET.
METHODS: To compare the myocardial glucose metabolism of normal subjects to patients with DM, we performed a quantitative FDG study during insulin clamp, oral glucose loading and fasting in nine normal volunteers and eight patients with noninsulin-dependent DM (NIDDM).
RESULTS: During oral glucose loading, myocardium-to-background (MB) ratio remarkably deteriorated in NIDDM patients compared with normals because of high plasma glucose and low serum insulin. Myocardial glucose utilization (MGU) rates in NIDDM patients were also lower than those in normal volunteers. MB ratio of FDG remarkably improved with insulin clamp in NIDDM patients compared with oral glucose loading. MGU rates during insulin clamp were still slightly lower than in the normal volunteers despite low plasma glucose and adequate plasma insulin.
CONCLUSION: The insulin clamp method may be very useful in NIDDM patients for improved myocardial FDG uptake compared to oral glucose loading or fasting, but slight decreases in MGU rates during insulin clamp in NIDDM patients may be because of insulin resistance (GluT4 abnormality).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884509

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  31 in total

1.  Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance.

Authors:  Janet B McGill; Linda R Peterson; Pilar Herrero; Ibrahim M Saeed; Carol Recklein; Andrew R Coggan; Amanda J Demoss; Kenneth B Schechtman; Carmen S Dence; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2011-04-23       Impact factor: 5.952

2.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

3.  Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans.

Authors:  Linda R Peterson; Ibrahim M Saeed; Janet B McGill; Pilar Herrero; Kenneth B Schechtman; Ratnasiri Gunawardena; Carol L Recklein; Andrew R Coggan; Amanda J DeMoss; Carmen S Dence; Robert J Gropler
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

4.  Viability assessment with MRI is superior to FDG-PET for viability: Pro.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

Review 5.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

6.  An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.

Authors:  James A Fallavollita; Andrew J Luisi; Edward Yun; Robert A deKemp; John M Canty
Journal:  J Nucl Cardiol       Date:  2010-04-14       Impact factor: 5.952

7.  Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.

Authors:  Kieren J Mather; Robert V Considine; LaTonya Hamilton; Niral A Patel; Carla Mathias; Wendy Territo; Adam G Goodwill; Johnathan D Tune; Mark A Green; Gary D Hutchins
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

8.  Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy.

Authors:  David P Kao; Ronald M Witteles; Andrew Quon; Joseph C Wu; Sanjiv Sam Gambhir; Michael B Fowler
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

9.  High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.

Authors:  Anisha A Gupte; Laurie J Minze; Maricela Reyes; Yuelan Ren; Xukui Wang; Gerd Brunner; Mohamad Ghosn; Andrea M Cordero-Reyes; Karen Ding; Domenico Pratico; Joel Morrisett; Zheng-Zheng Shi; Dale J Hamilton; Christopher J Lyon; Willa A Hsueh
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

10.  Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart.

Authors:  Hwi Jin Ko; Zhiyou Zhang; Dae Young Jung; John Y Jun; Zhexi Ma; Kelly E Jones; Sook Y Chan; Jason K Kim
Journal:  Diabetes       Date:  2009-08-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.